Clarity Pharmaceuticals Ltd

ASX:CU6 株式レポート

時価総額:AU$2.2b

Clarity Pharmaceuticals マネジメント

マネジメント 基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Michelle Parker

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間less than a year
CEOの所有権0.3%
経営陣の平均在職期間2.6yrs
取締役会の平均在任期間4.9yrs

経営陣の近況

Recent updates

We Think Clarity Pharmaceuticals (ASX:CU6) Can Easily Afford To Drive Business Growth

Sep 23
We Think Clarity Pharmaceuticals (ASX:CU6) Can Easily Afford To Drive Business Growth

Companies Like Clarity Pharmaceuticals (ASX:CU6) Are In A Position To Invest In Growth

Jan 03
Companies Like Clarity Pharmaceuticals (ASX:CU6) Are In A Position To Invest In Growth

We're Interested To See How Clarity Pharmaceuticals (ASX:CU6) Uses Its Cash Hoard To Grow

May 29
We're Interested To See How Clarity Pharmaceuticals (ASX:CU6) Uses Its Cash Hoard To Grow

Companies Like Clarity Pharmaceuticals (ASX:CU6) Are In A Position To Invest In Growth

Aug 24
Companies Like Clarity Pharmaceuticals (ASX:CU6) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About Clarity Pharmaceuticals' (ASX:CU6) Cash Burn Situation

Jan 13
Here's Why We're Not Too Worried About Clarity Pharmaceuticals' (ASX:CU6) Cash Burn Situation

CEO(最高経営責任者

Michelle Parker

less than a year

在職期間

Ms. Michelle Parker is Executive Director of Clarity Pharmaceuticals Ltd from August 2024 and is its Chief Executive Officer and MD. Ms. Parker joined the Clarity Pharmaceuticals Ltd in June 2018. She serv...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Alan Taylor
Executive Chairman11yrsAU$1.22m4.9%
A$ 110.0m
David Green
Chief Financial Officer2.6yrsAU$273.61kデータなし
Colin Biggin
COO & Non-Independent Executive Directorless than a yearAU$1.02m1.35%
A$ 30.4m
Michelle Parker
CEO, MD & Executive Directorno dataデータなし0.34%
A$ 7.6m
Matthew Harris
Chief Scientific Officerno dataAU$241.43k1.89%
A$ 42.5m
Lisa Sadetskaya
Director of Corporate Communications.no dataデータなしデータなし
Mary Bennett
Head of Human Resourceno dataデータなしデータなし
Shaemus Gleason
Executive Vice President of Operationsno dataデータなしデータなし
Othon Gervasio
Chief Medical Officerno dataデータなしデータなし
Robert Vickery
Company Secretaryno dataAU$268.69kデータなし

2.6yrs

平均在職期間

経験豊富な経営陣: CU6の経営陣は 経験豊富 であると考えられます ( 2.6年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Alan Taylor
Executive Chairman11yrsAU$1.22m4.9%
A$ 110.0m
Colin Biggin
COO & Non-Independent Executive Director5.1yrsAU$1.02m1.35%
A$ 30.4m
Michelle Parker
CEO, MD & Executive Directorless than a yearデータなし0.34%
A$ 7.6m
Christopher Roberts
Non-Executive Director8.7yrsAU$86.88k5.66%
A$ 127.0m
Thomas Ramdahl
Non-Executive Director5.7yrsAU$86.88k0.22%
A$ 5.0m
Neal Shore
Member of Scientific Advisory Board2.5yrsデータなしデータなし
Rosanne Robinson
Lead Independent Non-Executive Director14.1yrsAU$95.72k0.056%
A$ 1.2m
Jason Lewis
Member of Scientific Advisory Boardno dataデータなしデータなし
Oliver Sartor
Member of Scientific Advisory Board4.7yrsデータなしデータなし
Paul Donnelly
Member of Scientific Advisory Boardno dataデータなしデータなし
Andrei Iagaru
Member of Scientific Advisory Board2.6yrsデータなしデータなし
Louise Emmett
Member of Scientific Advisory Board2.4yrsデータなしデータなし

4.9yrs

平均在職期間

経験豊富なボード: CU6の 取締役会経験豊富 であると考えられます ( 4.9年の平均在任期間)。